ASCO 2021   

Questions discussed in this category


Given OlympiA trial with olaparib benefit for gBRCA+ patients?What are barriers that you foresee? In your practice who performs mutation testing and w...

Is DFS benefit in KN-564 in ASCO2021 sufficient evidence to change practice?

Given long term data from Keynote 052 for pembrolizumab presented at ASCO 2021. What factors impact your treatment decisions? For cis-ineligible PD-...


Papers discussed in this category


J. Clin. Oncol., 2011 Mar 28

BMC Cancer, 2017 Apr 28

The New England journal of medicine, 2016-12-08

J Clin Oncol, 2020 Jun 17

J Clin Oncol, 2020 Oct 29

N Engl J Med, 2021 Jun 03

Ann Surg Oncol, 2019 Jul 24

J Clin Oncol, 2020 Mar 03

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-02-20

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-08-20

Cancer, 2021 Mar 15

J Clin Oncol, 2015 Nov 1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024 Jan 04

N. Engl. J. Med.,

N. Engl. J. Med., 2017 Jun 04

Annals of oncology : official journal of the European Society for Medical Oncology, 2019-04-01

BMC Cancer, 2018 Mar 07

N Engl J Med,

JCO Oncol Pract, 2022 Jan 07